GSK announces further initiatives to advance openness and collaboration to help tackle global health challenges

GlaxoSmithKline: 10/11/12

  • Tuberculosis (TB) ‘compound library’ to be made available to help stimulate research into TB
  • Investment in GSK’s Tres Cantos Open Lab to be doubled with an additional £5m funding awarded
  • Detailed data from GSK clinical trials to be made available to researchers to further scientific understanding and knowledge

GSK today announced new measures to further advance its commitment towards greater openness, transparency and collaboration. Speaking at a meeting hosted by the Wellcome Trust in London today, GSK CEO Sir Andrew Witty will outline new steps to build on the encouraging signs of progress resulting from GSK’s ‘open innovation’ approach to R&D, designed to help develop new solutions for the world’s most serious health challenges. Read more